Penn Study Sheds Light On The Complexity Of Gene Therapy For Congenital Blindness
New research from the Scheie Eye Institute finds that gene therapy for Leber congenital amaurosis (LCA) shows long-term improvement in vision as well as advancing degeneration of affected retinal cells. MVRF proudly supported this beneficial study. Read the press release here!


